The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

THE PRESENT STATUS OF DILANTIN THERAPY

Published Online:https://doi.org/10.1176/ajp.98.4.515

1. We believe that, at the present time, dilantin sodium is the most effective single preparation available in the treatment of the convulsive manifestations of epilepsy.

2. Although toxic manifestations are frequent and sometimes severe, careful clinical observation and laboratory studies will decrease their incidence and withdrawal of the drug or reduction in dosage will afford prompt relief.

3. The use of small doses of phenobarbital in combination with dilantin offers an additional possibility for the control of seizures when dilantin alone is insufficient to attain that end.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.